Vol. 7, Issue 2, Part B (2025)

Background: Epistaxis represents a very frequent clinical manifestation in the general population. It is estimated that around 60% of people were affected. The first aim of this study is to compare the results of the pharmacological to the surgical treatment and establishing which of the two was the most effective. Subsequently we observe some factors that can favor the choice of surgical treatment. Methods: In this study we describe the results relating to 121 patients suffering from recurrent anterior epistaxis treated at our ENT Departement between 2017 and 2020. Results: Surgery has proven to be more effective than pharmacological treatment in the treatment of recurrent anterior epistaxis, particularly in patients suffering from comorbidities such as arterial hypertension and coagulopathy and in patients on anticoagulant therapy. Conclusions: The surgical treatment has proven to be very effective and safe and we consider it the treatment of choice even in decoagulated patients or suffer from other significant comorbidities